A US mum says a new Wegovy weight-loss pill has helped restart her progress after injections proved too expensive. Sharon ...

Meanwhile, Novo Nordisk said Tuesday that fourth-quarter sales of Wegovy rose 17% on year at constant exchange rates to 21.86 billion Danish kroner ($3.46 billion), while sales of Ozempic rose 1% to ...

A mom who couldn’t afford GLP-1 injections has started the new “cheaper” Wegovy pill – and says she has no side effects. Sharon Vickers, 46, has struggled with her weight all her life and at her ...

Novo Nordisk expects a decline in sales of up to 13 per cent this year as the Danish drugmaker competes in an increasingly crowded obesity-treatment market and faces pressure on the pricing of its ...

Novo's warning ends a years-long run of double-digit percentage gains in profits and sales since the launch of Wegovy in June ...

Novo Nordisk's shares plunged as much as 20% on Wednesday as the Danish obesity drug giant warned it would face ...

Novo Nordisk's stock plunged Tuesday after the maker of diabetes and weight-loss drugs Ozempic and Wegovy said it expects ...

In the world of obesity research, the arrival of GLP-1 drugs like Ozempic feels seismic. At a recent conference, Martin Binks, a leader in obesity research, found himself marveling with a colleague: ...

The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key ...

By Jacob Gronholt-Pedersen and Maggie Fick COPENHAGEN, Feb 3 (Reuters) - Wegovy maker Novo Nordisk warned on Tuesday that ...

“Protein is particularly effective at stimulating GLP-1, while fibre feeds gut bacteria that produce short-chain fatty acids, ...

While CagriSema bested Novo Nordisk's Wegovy on blood sugar control in a late-stage trial, the next-gen weight loss drug still has not met the pharma's 25% weight loss goal.